Drugplain

Orilissa 200 mg/1

Elagolix · TABLET, FILM COATED · AbbVie Inc.

No Recall History
Plain English

Orilissa is a prescription tablet taken by mouth to treat endometriosis pain in women. It works by reducing estrogen levels in the body to help decrease pain associated with this condition.

Key Facts

Brand Name
Orilissa
Generic Name
Elagolix
NDC Code (Product)
0074-0039
Manufacturer
AbbVie Inc.
Strength
200 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Marketing Status
Application #
NDA210450
Marketing Start
07/23/2018

Recall History

No Recall History

Frequently Asked Questions

What is Orilissa used for?

Orilissa is a prescription tablet taken by mouth to treat endometriosis pain in women. It works by reducing estrogen levels in the body to help decrease pain associated with this condition.

Is Orilissa a controlled substance?

Orilissa is not classified as a controlled substance by the DEA.

What is the generic name for Orilissa?

The generic name for Orilissa is Elagolix. There are 1 other brand versions of Elagolix.

What is the NDC code for Orilissa 200 mg/1?

The NDC (National Drug Code) for Orilissa 200 mg/1 is 0074-0039, listed by AbbVie Inc..

Product NDC

0074-0039

Package NDC

0074-0039-14

Other Orilissa Dosages

Other Elagolix Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)